美丽的研究:强调心率的重要性

Primary Care Cardiovascular Journal (pccj) Pub Date : 1900-01-01 DOI:10.3132/PCCJ.2008.042

S. Jarvis

{"title":"美丽的研究:强调心率的重要性","authors":"S. Jarvis","doi":"10.3132/PCCJ.2008.042","DOIUrl":null,"url":null,"abstract":"So, it was with bated breath that some observers waited for the results of a new placebo controlled study – the BEAUTIFUL study – looking at the effects of ivabradine (Procorolan), an If current inhibitor of the sinus node. The only drug in its class, ivabradine is a pure heart rate reducing drug, without the effects on blood pressure and the catecholamine system found with beta blocking drugs. At present it is licensed as an anti-anginal medication. 6","PeriodicalId":308856,"journal":{"name":"Primary Care Cardiovascular Journal (pccj)","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The BEAUTIFUL study: underlining the importance of heart rate\",\"authors\":\"S. Jarvis\",\"doi\":\"10.3132/PCCJ.2008.042\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"So, it was with bated breath that some observers waited for the results of a new placebo controlled study – the BEAUTIFUL study – looking at the effects of ivabradine (Procorolan), an If current inhibitor of the sinus node. The only drug in its class, ivabradine is a pure heart rate reducing drug, without the effects on blood pressure and the catecholamine system found with beta blocking drugs. At present it is licensed as an anti-anginal medication. 6\",\"PeriodicalId\":308856,\"journal\":{\"name\":\"Primary Care Cardiovascular Journal (pccj)\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1900-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Primary Care Cardiovascular Journal (pccj)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3132/PCCJ.2008.042\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Primary Care Cardiovascular Journal (pccj)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3132/PCCJ.2008.042","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

因此，一些观察者屏息以待一项新的安慰剂对照研究的结果——BEAUTIFUL研究——观察伊伐布雷定(Procorolan)的效果，一种目前的窦房结抑制剂。伊瓦布雷定是同类药物中唯一的一种纯降心率药物，对血压和儿茶酚胺系统没有阻断药物的影响。目前，它被许可作为一种抗心绞痛药物。6

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

The BEAUTIFUL study: underlining the importance of heart rate

So, it was with bated breath that some observers waited for the results of a new placebo controlled study – the BEAUTIFUL study – looking at the effects of ivabradine (Procorolan), an If current inhibitor of the sinus node. The only drug in its class, ivabradine is a pure heart rate reducing drug, without the effects on blood pressure and the catecholamine system found with beta blocking drugs. At present it is licensed as an anti-anginal medication. 6

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Primary Care Cardiovascular Journal (pccj)

自引率

0.00%

发文量

期刊最新文献

Statin prescribing in Europe: A comparison of differences and potential impact on health outcomes Atrial fibrillation: which patients should be managed in primary, secondary and tertiary care? How well are we doing in lipid management Assessing cardiovascular risk in the 10-minute consultation Smoking cessation 1: Choosing the right pharmacotherapy for each patient